These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1579141)

  • 1. Oral milrinone in severe chronic heart failure.
    Desjardins S
    N Engl J Med; 1992 Jun; 326(23):1565; author reply 1567. PubMed ID: 1579141
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral milrinone in severe chronic heart failure.
    Feldman AM; Baughman KL; Strobeck JE
    N Engl J Med; 1992 Jun; 326(23):1565-6; author reply 1567. PubMed ID: 1579142
    [No Abstract]   [Full Text] [Related]  

  • 3. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR
    Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoximone and milrinone--inotropic vasodilators for severe heart failure.
    Drug Ther Bull; 1991 May; 29(10):39-40. PubMed ID: 1834448
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal.
    Monrad ES; Baim DS; Smith HS; Lanoue AS; Silverman KJ; Gervino EV; Grossman W
    Circulation; 1986 Mar; 73(3 Pt 2):III205-12. PubMed ID: 3510776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
    DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
    N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial and vascular effects of intracoronary versus intravenous milrinone.
    Colucci WS; Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E
    Trans Assoc Am Physicians; 1985; 98():136-45. PubMed ID: 3842193
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous milrinone: therapeutic responses in heart failure.
    Braunwald E
    Am Heart J; 1991 Jun; 121(6 Pt 2):1937-8. PubMed ID: 2035423
    [No Abstract]   [Full Text] [Related]  

  • 11. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Feb; 314(6):349-58. PubMed ID: 2418353
    [No Abstract]   [Full Text] [Related]  

  • 12. New positive inotropic agents for congestive heart failure.
    N Engl J Med; 1986 Aug; 315(6):396-7. PubMed ID: 3736614
    [No Abstract]   [Full Text] [Related]  

  • 13. Milrinone: a positive inotropic vasodilator.
    Colucci WS; Jaski BE; Fifer MA; Wright RF; Braunwald E
    Trans Assoc Am Physicians; 1984; 97():124-33. PubMed ID: 6535335
    [No Abstract]   [Full Text] [Related]  

  • 14. Criteria for use of intravenous milrinone in adult inpatients.
    Shubert J; Mancano MA; Pina IL; Milfred SK
    Am J Health Syst Pharm; 1995 Sep; 52(17):1918-9. PubMed ID: 8528858
    [No Abstract]   [Full Text] [Related]  

  • 15. Inotropic therapy for heart failure--an unfulfilled promise.
    Curfman GD
    N Engl J Med; 1991 Nov; 325(21):1509-10. PubMed ID: 1944430
    [No Abstract]   [Full Text] [Related]  

  • 16. Milrinone for long-term therapy of severe heart failure: clinical experience with special reference to maximal exercise tolerance.
    LeJemtel TH; Gumbardo D; Chadwick B; Rutman HI; Sonnenblick EH
    Circulation; 1986 Mar; 73(3 Pt 2):III213-8. PubMed ID: 3510777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of the use of milrinone in the treatment of acute crisis in patients with congestive heart failure].
    Gun C; Piegas LS; Bianco AC; Freire RB; Ramos RF; Timerman A
    Arq Bras Cardiol; 1995 Sep; 65(3):255-8. PubMed ID: 8579514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic therapy for heart failure: paradise postponed.
    Cohn JN
    N Engl J Med; 1989 Mar; 320(11):729-31. PubMed ID: 2922016
    [No Abstract]   [Full Text] [Related]  

  • 19. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New inotropic agents in the treatment of refractory congestive heart failure].
    Hertzeanu H; Pines A
    Harefuah; 1988 Mar; 114(6):290-3. PubMed ID: 3286406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.